Peter Doshi

Peter Doshi is an associate professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy and a senior editor at The BMJ. His work bridges academia and public health policy, focusing on clinical trial transparency, drug approval processes, and the integrity of biomedical evidence.

Education:

• A.B. in Anthropology, Brown University
• A.M. in East Asian Studies, Harvard University
• Ph.D. in History, Anthropology, and Science, Technology and Society, MIT
• Fellowship in Comparative Effectiveness Research, Johns Hopkins University

His research interests include clinical trial transparency, evidence-based medicine, vaccine policy, and pharmaceutical regulation. He has extensively analyzed the use of regulatory data in systematic reviews, particularly in influenza antivirals and COVID-19 vaccines. His work challenges assumptions about drug efficacy and calls for greater access to raw clinical trial data.

Doshi's recent publications reveal a strong trend toward analyzing methodological flaws in vaccine trials, regulatory oversight, and bias in observational studies. He consistently advocates for transparency and scientific rigor in public health decision-making.

Scientific Awards:

• New Investigator Award, American Association of Colleges of Pharmacy (2015)
• Included in The Wired 'Smart List' (2013)

Doshi leads the RIAT Support Center (Restoring Invisible and Abandoned Trials), funded by the Laura and John Arnold Foundation, which aims to correct the scientific record by promoting accurate and complete trial reporting. He has received grants from PCORI, Cochrane, NIHR, and CIHR. He has served on advisory panels for the European Medicines Agency and presented to the Institute of Medicine. He frequently contributes to public discourse through op-eds in The New York Times, The BMJ, and testimony before regulatory bodies.